Model | Relative Odds of Left Ventricular Hypertrophy (95% Confidence Interval) | Mean LVMI z-Score (95% Confidence Interval) |
---|---|---|

Model 1 | ||

FGF23, RU/ml | ||

<100 | Reference | Reference |

100–169 | 1.98 (1.04 to 3.79)^{a} | 0.30 (0.06 to 0.54)^{a} |

≥170 | 2.41 (1.25 to 4.62)^{b} | 0.29 (0.04 to 0.55)^{a} |

FGF23, per doubling | 1.38 (1.12 to 1.71)^{b} | 0.14 (0.04 to 0.23)^{b} |

Model 2 | ||

FGF23, RU/ml | ||

<100 | Reference | Reference |

100–169 | 1.78 (0.90 to 3.52) | 0.30 (0.07 to 0.54)^{a} |

≥170 | 2.53 (1.28 to 4.97)^{b} | 0.32 (0.07 to 0.57)^{a} |

FGF23, per doubling | 1.43 (1.13 to 1.81)^{b} | 0.14 (0.04 to 0.23)^{b} |

Model 3 | ||

FGF23, RU/ml | ||

<100 | Reference | Reference |

100–169 | 1.31 (0.62 to 2.77) | 0.15 (−0.09 to 0.40) |

≥170 | 1.44 (0.66 to 3.17) | −0.02 (−0.29 to 0.25) |

FGF23, per doubling | 1.13 (0.85 to 1.50) | 0.01 (−0.10 to 0.11) |

Model 1: unadjusted. Model 2: additionally adjusted for age, sex, race, and body mass index. Model 3: additionally adjusted for systolic BP

*z*-score, hemoglobin*z*-score, use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers, and eGFR. FGF23, fibroblast growth factor 23; LVMI, left ventricular mass index.↵a

*P*<0.05.↵b

*P*<0.01.